Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jun 28, 2007 at 9:08 AM EDT

CryoCor Regains Lost Ground; FDA Remains Unpredictable (CRYO)

CryoCor Inc. (CRYO-NASDAQ) is trading up almost 100% in early trading today. Last night the company announced that an FDA…

Douglas A. McIntyre | Jun 27, 2007 at 12:36 PM EDT

Short Selling Volatile Biotechs (June 2007) (DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO)

Stock Tickers: DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO Many of the recent biotech implosions are always interesting to…

Douglas A. McIntyre | Jun 26, 2007 at 4:03 PM EDT

Nuvelo Loses Bayer as Development Partner in Stroke Treatment (NUVO, BAY)

Nuvelo, Inc. (NUVO-NASDAQ) dropped the bomb today with the announcement that it will resume development of alfimeprase, its lead investigational…

Douglas A. McIntyre | Jun 25, 2007 at 7:55 AM EDT

Safeguard Scientifics CEO Interview: “Small Cap Value Stock” (SFE, CLRT, CMGI, ICGE)

Stock Tickers: SFE, CLRT, CMGI, ICGE Late last week, 24/7 Wall St. got the chance to interview Peter J. Boni,…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | Jun 23, 2007 at 11:45 AM EDT

Orexigen Therapeutics: Tricking the Mind Out of Being Fat (OREX)

Orexigen Therapeutics, Inc. (OREX-NASDAQ), a biopharmaceutical with an initial focus on obesity, has announced that data presented today at the…

Douglas A. McIntyre | Jun 20, 2007 at 5:10 PM EDT

Obama & Clinton Criticize Bush Stem Cell Veto (STEM, GERN, ASTM)

Stock Tickers: STEM, GERN, ASTM Senator Obama has issued a statement regarding President Bush’s veto of the Embryonic Stem Cell…

Douglas A. McIntyre | Jun 20, 2007 at 4:37 PM EDT

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Shares of microcap biotech Coley Pharmaceutical Group (COLY-NASDAQ) saw shares get pounded late on Wednesday afternoon. Right before 2:00 PM…

Douglas A. McIntyre | Jun 19, 2007 at 6:54 AM EDT

Biotech Implosion: Allos Therapeutics (ALTH)

Allos Therapeutics, Inc. (ALTH-NASDAQ) is indicated down almost 20% in thin pre-market trading after it announced that top line results…

Douglas A. McIntyre | Jun 18, 2007 at 8:37 AM EDT

IPO Filing: MAP Pharmaceuticals, the New Inhaler

A new inhaled-molecule company named MAP Pharmaceuticals, Inc. has filed for an IPO. Underwriters are listed as Merrill lynch, Morgan…

Douglas A. McIntyre | Jun 18, 2007 at 3:31 AM EDT

Lexicon Pharmaceuticals: Back From The Depths With New Investors (LXRX)

Lexicon Pharmaceuticals, Inc. (LXRX-NASDAQ) is a biotech company that many have not heard of, and those who do know it…

Douglas A. McIntyre | Jun 15, 2007 at 5:45 PM EDT

Cramer Speculates in CV Therapeutics (CVTX)

On tonight’s Mad Money on CNBC, Jim Cramer had his normal ‘Speculation Friday’ and talked CV Therapeutics (CVTX) for a…

Douglas A. McIntyre | Jun 15, 2007 at 11:06 AM EDT

Options Expiration Weighing on Dendreon (DNDN)

Dendreon (DNDN) has seen a lot of the old hyperactive trading volume come out of the stock now that it…

Douglas A. McIntyre | Jun 13, 2007 at 1:04 PM EDT

New Threat for GlaxoSmithKline: Avandia Spammers (GSK)

GlaxoSmithKline (GSK-NYSE) has been under significant pressure of late because of the New England Journal of Medicine showing greatly increased…

Douglas A. McIntyre | Jun 12, 2007 at 5:53 PM EDT

Cramer’s Picks & Pans in Pharmaceuticals

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said…

1 … 367 368 369 370 371 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

CryoCor Regains Lost Ground; FDA Remains Unpredictable (CRYO)

Short Selling Volatile Biotechs (June 2007) (DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO)

Nuvelo Loses Bayer as Development Partner in Stroke Treatment (NUVO, BAY)

Safeguard Scientifics CEO Interview: “Small Cap Value Stock” (SFE, CLRT, CMGI, ICGE)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Orexigen Therapeutics: Tricking the Mind Out of Being Fat (OREX)

Obama & Clinton Criticize Bush Stem Cell Veto (STEM, GERN, ASTM)

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Biotech Implosion: Allos Therapeutics (ALTH)

IPO Filing: MAP Pharmaceuticals, the New Inhaler

Lexicon Pharmaceuticals: Back From The Depths With New Investors (LXRX)

Cramer Speculates in CV Therapeutics (CVTX)

Options Expiration Weighing on Dendreon (DNDN)

New Threat for GlaxoSmithKline: Avandia Spammers (GSK)

Cramer’s Picks & Pans in Pharmaceuticals

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

CryoCor Regains Lost Ground; FDA Remains Unpredictable (CRYO)

Short Selling Volatile Biotechs (June 2007) (DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO)

Nuvelo Loses Bayer as Development Partner in Stroke Treatment (NUVO, BAY)

Safeguard Scientifics CEO Interview: “Small Cap Value Stock” (SFE, CLRT, CMGI, ICGE)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Orexigen Therapeutics: Tricking the Mind Out of Being Fat (OREX)

Obama & Clinton Criticize Bush Stem Cell Veto (STEM, GERN, ASTM)

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Biotech Implosion: Allos Therapeutics (ALTH)

IPO Filing: MAP Pharmaceuticals, the New Inhaler

Lexicon Pharmaceuticals: Back From The Depths With New Investors (LXRX)

Cramer Speculates in CV Therapeutics (CVTX)

Options Expiration Weighing on Dendreon (DNDN)

New Threat for GlaxoSmithKline: Avandia Spammers (GSK)

Cramer’s Picks & Pans in Pharmaceuticals

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%